These antibodies or iBodies are different from anything else in the market. The company Adalta discovered it in sharks as a single chain antibodies and modified it so that they don't get degraded easily in the system unlike other monoclonal antibodies. IF the human trials are promising (underway as understand), this has a huge potential!
1AD Price at posting:
23.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)